YME1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.732400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.196400E-01
Normal-vs-Stage2
9.794600E-01
Normal-vs-Stage3
3.506000E-01
Normal-vs-Stage4
2.986600E-01
Stage1-vs-Stage2
8.682600E-01
Stage1-vs-Stage3
3.996200E-01
Stage1-vs-Stage4
2.265200E-01
Stage2-vs-Stage3
3.051200E-01
Stage2-vs-Stage4
2.097000E-01
Stage3-vs-Stage4
8.944000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.336200E-01
Normal-vs-AfricanAmerican
4.722600E-01
Normal-vs-Asian
8.015200E-01
Caucasian-vs-AfricanAmerican
1.980180E-01
Caucasian-vs-Asian
6.887600E-01
AfricanAmerican-vs-Asian
2.502600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.322600E-01
Normal-vs-Female
9.705400E-01
Male-vs-Female
6.380000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.370600E-01
Normal-vs-Age(41-60Yrs)
5.991200E-01
Normal-vs-Age(61-80Yrs)
7.798200E-01
Normal-vs-Age(81-100Yrs)
6.423200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.728600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.417000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.662200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.600700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.810200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.208400E-01
Normal-vs-Daily Drinker
6.141600E-01
Normal-vs-Weekly Drinker
8.634000E-01
Normal-vs-Occasional Drinker
6.847200E-01
Normal-vs-Social Drinker
8.138400E-01
Non Drinker-vs-Daily Drinker
9.299400E-01
Non Drinker-vs-Weekly Drinker
5.919000E-01
Non Drinker-vs-Occasional Drinker
7.570200E-02
Non Drinker-vs-Social Drinker
6.752600E-01
Daily Drinker-vs-Weekly Drinker
5.757800E-01
Daily Drinker-vs-Occasional Drinker
9.207800E-02
Daily Drinker-vs-Social Drinker
6.503000E-01
Weekly Drinker-vs-Occasional Drinker
3.297000E-01
Weekly Drinker-vs-Social Drinker
9.173400E-01
Occasional Drinker-vs-Social Drinker
2.723200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.961800E-01
Normal-vs-Grade 2
5.537000E-01
Normal-vs-Grade 3
9.022400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.590100E-02
Grade 1-vs-Grade 3
8.356400E-02
Grade 1-vs-Grade 4
2.961800E-01
Grade 2-vs-Grade 3
9.205000E-01
Grade 2-vs-Grade 4
5.537000E-01
Grade 3-vs-Grade 4
9.022400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.115400E-01
Normal-vs-NonDiabetic
8.211000E-01
Diabetic-vs-NonDiabetic
9.901200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.663600E-01
Normal-vs-NoPancreatitis
8.723400E-01
Pancreatitis-vs-NoPancreatitis
7.245400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.056000E-01
Normal-vs-N1
9.837000E-01
N0-vs-N1
6.609600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.100000E-01
Normal-vs-TP53-NonMutant
8.548800E-01
TP53-Mutant-vs-TP53-NonMutant
2.014100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
